Related Experiment Video
Updated: Aug 14, 2026

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
Published on: June 4, 2021
[Treatment of venous thromboembolic disease]
1Service de médecine vasculaire, Hôpital Broussais, Paris.
Except for the indications of thrombolytic treatment in severe pulmonary embolism, anticoagulant drugs are the treatment of venous thromboembolism. Low molecular weight heparins once or twice a day are at present the treatment of choice for deep venous thrombosis, however they do not have the legal indication for pulmonary embolism yet. Oral anticoagulants are started as soon as possible and are continued for at least 12 weeks with an INR maintained between 2 and 3. The use of low molecular weight heparins as long term treatment is at present in evaluation but seems promising. Early mobilization associated with compression stockings is an important part of the treatment.
Except for the indications of thrombolytic treatment in severe pulmonary embolism, anticoagulant drugs are the treatment of venous thromboembolism. Low molecular weight heparins once or twice a day are at present the treatment of choice for deep venous thrombosis, however they do not have the legal indication for pulmonary embolism yet. Oral anticoagulants are started as soon as possible and are continued for at least 12 weeks with an INR maintained between 2 and 3. The use of low molecular weight heparins as long term treatment is at present in evaluation but seems promising. Early mobilization associated with compression stockings is an important part of the treatment.
Related Concept Videos
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism III: Nursing Management

